PHOENIX, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (CELZ), (the “Company”), a clinical-stage biotechnology company pioneering regenerative immunotherapy, today ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. They’re a mission to unite the city’s ...
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) announced that its stockholders approved a proposal to allow the full exercise of warrants to purchase 2,790,340 shares of common stock. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback